Martin B. Brenner
2023
In 2023, Martin B. Brenner earned a total compensation of $1.1M as Chief Executive Officer and Chief Scientific Officer at iBio.
Compensation breakdown
Bonus | $250 |
---|---|
Non-Equity Incentive Plan | $110,916 |
Option Awards | $175,504 |
Salary | $457,553 |
Stock Awards | $316,359 |
Other | $8,592 |
Total | $1,069,174 |
Brenner received $457.6K in salary, accounting for 43% of the total pay in 2023.
Brenner also received $250 in bonus, $110.9K in non-equity incentive plan, $175.5K in option awards, $316.4K in stock awards and $8.6K in other compensation.
Rankings
In 2023, Martin B. Brenner's compensation ranked 1,138th out of 3,006 executives tracked by ExecPay. In other words, Brenner earned more than 62.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,138 out of 3,006 | 62nd |
Division Manufacturing | 678 out of 1,650 | 59th |
Major group Chemicals And Allied Products | 458 out of 918 | 50th |
Industry group Drugs | 447 out of 881 | 49th |
Industry Pharmaceutical Preparations | 307 out of 637 | 52nd |
Source: SEC filing on October 10, 2024.
Brenner's colleagues
We found one more compensation record of an executive who worked with Martin B. Brenner at iBio in 2023.
2023
Felipe Duran
iBio